Brief introduction of Jilin Changyuan Pharmaceutical Co., Ltd.

It has a well-equipped workshop for pre-extraction of large-capacity injections, solid preparations and traditional Chinese medicines, and can produce five dosage forms, including large-capacity injections, tablets, capsules, granules and water pills, with more than 90 varieties, among which: Changyuan Anxue-succinyl gelatin injection, Haidan capsule, brain peptide capsule and brain suppository rehabilitation capsule are all national new drugs or exclusive varieties. These varieties have reasonable prices and remarkable effects. The company also has a central laboratory that meets the national standards. Most of its testing equipment is the most advanced first-class equipment in the world. At the same time, it is equipped with inspection technicians with many years of inspection experience, exquisite skills and profound knowledge, which plays a guarantee role in producing qualified products that meet the requirements of national standards.

For the company's sustainable development, the company has invested a lot of money to jointly develop new products with relevant universities and research institutes, including compound succinyl gelatin injection (class I chemical medicine), edaravone injection (exclusive in China), Ginkgo biloba injection (class II traditional Chinese medicine) and other varieties. These varieties have broad market prospects and high added value, which will certainly bring considerable output value and profits and taxes to enterprises and lay a good foundation for their subsequent development.